Entries of Ghibelli, Lina on the publication server

Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht and Heudobler, Daniel (2026) Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias. Frontiers in Pharmacology 17.

Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht and Heudobler, Daniel (2025) MEPED as salvage therapy for relapsed/refractory Hodgkin’s lymphoma incorporating edited non-oncogene addiction: mTOR as a bottleneck. Frontiers in Pharmacology 16.

Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht and Heudobler, Daniel (2024) Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity. Frontiers in Oncology 13.

Harrer, Dennis Christoph , Lüke, Florian , Pukrop, Tobias , Ghibelli, Lina, Reichle, Albrecht and Heudobler, Daniel (2023) Addressing Genetic Tumor Heterogeneity, Post-Therapy Metastatic Spread, Cancer Repopulation, and Development of Acquired Tumor Cell Resistance. Cancers 16 (1), p. 180.

Pelliccia, Andrea , Capradossi, Francesco , Corsi, Francesca , Tarquini, Greta Deidda, Bruni, Emanuele, Reichle, Albrecht , Torino, Francesco and Ghibelli, Lina (2023) Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition. International Journal of Molecular Sciences 24 (3), p. 2040. Fulltext not available.

Lüke, Florian , Harrer, Dennis Christoph, Pantziarka, Pan , Pukrop, Tobias , Ghibelli, Lina, Gerner, Christopher , Reichle, Albrecht and Heudobler, Daniel (2022) Drug Repurposing by Tumor Tissue Editing. Frontiers in Oncology 2022 (12), p. 900985.

Heudobler, Daniel, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Pukrop, Tobias , Herr, Wolfgang, Gerner, Christopher , Pantziarka, Pan, Ghibelli, Lina and Reichle, Albrecht (2019) Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction. Frontiers in Oncology 9 (1408), pp. 1-22.

Pantziarka, Pan , Ghibelli, Lina and Reichle, Albrecht (2019) A Computational Model of Tumor Growth and Anakoinosis. Frontiers in Pharmacology 10 (287), pp. 1-14.

Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Klobuch, Sebastian, Thomas, Simone, Pukrop, Tobias, Hackl, Christina, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher and Reichle, Albrecht (2018) Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis. Frontiers in Pharmacology 9 (1357), pp. 1-26.

Klobuch, Sebastian, Steinberg, Tim, Bruni, Emanuele, Mirbeth, Carina, Heilmeier, Bernhard, Ghibelli, Lina, Herr, Wolfgang, Reichle, Albrecht and Thomas, Simone (2018) Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis. Frontiers in Pharmacology 9 (1380), pp. 1-11.

Heudobler, Daniel, Rechenmacher, Michael, Lüke, Florian, Vogelhuber, Martin, Pukrop, Tobias, Herr, Wolfgang, Ghibelli, Lina, Gerner, Christopher and Reichle, Albrecht (2018) Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue. International Journal of Molecular Sciences 19 (11), p. 3540.

Bruni, Emanuele, Reichle, Albrecht, Scimeca, Manuel, Bonanno, Elena and Ghibelli, Lina (2018) Lowering Etoposide Doses Shifts Cell Demise From Caspase-Dependent to Differentiation and Caspase-3-Independent Apoptosis via DNA Damage Response, Inducing AML Culture Extinction. Frontiers in Pharmacology 9. Fulltext not available.